ArticleBiological trace element research2026
Omega 3 Fatty Acids Mitigate Monosodium Glutamate (MSG)-Induced Developmental Toxicity via Hepcidin/NF-κB Pathway Modulation and Iron Homeostasis Restoration in Male Rats.
Article in Biological trace element research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Monosodium glutamate (MSG), a widely used flavor enhancer, acts as an excitatory neurotransmitter agonist. Excessive exposure during development can lead to excitotoxicity, characterized by overstimulation of glutamate receptors, neuronal injury, and systemic oxidative stress. This study investigated the effects of perinatal MSG exposure on male offspring and the protective role of omega 3 fatty acids supplementation. Forty-eight pregnant Wistar rats were divided into four groups: Control, MSG (10 mg/g, gestational day 1 to postnatal day 0), omega 3 fatty acids + MSG (185 mg/kg omega 3 fatty acids plus MSG), and omega 3 fatty acids alone. We assessed forty-eight male offspring (n=12/group) at postnatal day 21 using biochemical, hematological, molecular, and histopathological analyses. MSG exposure caused substantial maternal mortality (16.67%) and significantly reduced offspring survival (54.54%). In surviving offspring, it induced liver injury, iron overload, inflammation, anemia, and organ dysfunction. Omega 3 fatty acids supplementation was highly effective, preventing maternal mortality (100% vs 83.33% survival in the MSG group) and substantially restoring iron homeostasis and tissue architecture. It also reduced key inflammatory markers (IL-1β, IL-6, TNF-α) by over 80%. Our novel findings include non-transferrin-bound iron (NTBI) and tissue-specific microRNAs (miR-122, miR-192, miR-223), which have not previously been reported as MSG toxicity indicators, reveal a 1,150% increase in NTBI, hepatic iron accumulation, and disrupted gene expression of iron-related proteins (hepcidin antimicrobial peptide 1, ferritin light chain, transferrin receptor 1, aminolevulinate synthase 1). We also observed significant upregulation (p < 0.001) of microRNAs miR-122, miR-192, and miR-223 by 700%, 400%, and 500%, respectively. Histopathological examination confirmed severe liver damage in the MSG group. Mechanistically, Omega 3 fatty acids restored hepatic architecture and reduced renal and splenic inflammatory infiltration, as confirmed by histopathology, enhanced antioxidant defenses, downregulated hepcidin, suppressed the nuclear factor kappa-light-chain-enhancer of activated B cells signaling pathway, and modulated these key epigenetic mechanisms. These results identify novel biomarkers for MSG toxicity and support Omega 3 fatty acids as a promising developmental protective intervention.
Indexed as
Identifiers
41680585What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.